CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Shares withheld for taxes Chief Business Officer gave up 6,421 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 8-K/A Event Executive or director change
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations · Executive or director change
- SC 13G Stake Amended Statement of Ownership
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,536 shares (to pay taxes)
- 4 Shares withheld for taxes Pres and CEO gave up 9,125 shares (to pay taxes)
- 8-K Event Exit or restructuring costs · Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Chief Scientific Officer sold 6,000 shares at $5.08 ($30,460)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
Page 11 of 44 · 872 filings